Wall Street has grown more confident that insurers in the Medicare Advantage market for seniors are taming elevated medical spending. But when it comes to Medicaid, a joint federal and state program serving lower-income beneficiaries, the market isn't as sure.

Molina Healthcare is next to face investors on this point. The company, which sees most of its revenue from managed Medicaid, is set to release results Wednesday after market close. Shares have gained more than 30.5% this year after a challenging 2025.

"Investor focus is now increasingly centered on whether Medicaid cost trends reaccelerate into 2Q26 as peers have begun to flag incremental pressure," Goldman Sachs analyst Scott Fidel said of Molina in a July 14 note.

The stock edged down about 7% over two days last week, after insurers Elevance Health and UnitedHealth Group spoke of continuing Medicaid cost pressures on their respective second-quarter earnings calls July 15 and July 16.

At Molina, analysts expect adjusted earnings per share of $1.39, according to FactSet, down from $5.48 the same quarter last year. The consensus estimate for quarterly revenue is $10.83 billion, down from $11.43 billion a year ago.

The company's medical cost ratio -- a measure of what percentage of premium revenue is being spent on claims -- is expected to come in at 92.4%, higher than 90.4% the same quarter last year.

All in all, Molina's stock has performed better this year compared with 2025, when shares lost 40%. Management has characterized 2026 Medicaid margins as a "trough" that can improve going forward. Against moderated expectations, Molina beat consensus estimates on earnings and the medical cost ratio in the first quarter.

The market sent shares up 14% on that first-quarter announcement, and the price has continued to gain since.

The stock has an average Hold rating and target price of $209.59.

TD Cowen analyst Ryan Langston says while he believes Molina is "uniquely positioned to grow" through contract wins and acquisitions, his Hold rating reflects a "challenging macro environment," such as states contending with budget deficits.

Management said even though the first-quarter was strong, Molina would wait another quarter to update full-year guidance.

Langston saw that decision stemming from an "abundance of caution" -- and anticipates an increase.

"We expect MOH to raise FY26 guidance above their current 'at least' $5.00/share," Langston wrote in a July 14 note. Langston estimates adjusted EPS of $5.50 for the year.

Write to Catherine Dunn at catherine.dunn@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

July 22, 2026 02:00 ET (06:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.